{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:15:22Z","timestamp":1780575322499,"version":"3.54.1"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:00:00Z","timestamp":1666051200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>In an end-stage midgut neuroendocrine tumor patient with carcinoid heart disease, right ventricular dysfunction, mildly reduced renal function, and refractory to 6 cycles of <jats:sup>177<\/jats:sup>Lu-HA-DOTATATE therapy, planar, and 22 hours SPECT\/CT images were acquired after injection of 224 MBq of <jats:sup>203<\/jats:sup>Pb-VMT-\u03b1-NET to assess the feasibility of performing <jats:sup>212<\/jats:sup>Pb-VMT-\u03b1-NET therapy. A comparison of the 1.5 and 22 hours SPECT\/CT images with <jats:sup>68<\/jats:sup>Ga-HA-DOTATATE PET\/CT showed high uptake of <jats:sup>203<\/jats:sup>Pb-VMT-\u03b1-NET in liver metastases matching with the results of the PET\/CT investigation.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004464","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T22:00:05Z","timestamp":1666130405000},"page":"54-55","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["203Pb-VMT-\u03b1-NET Scintigraphy of a Patient With Neuroendocrine Tumor"],"prefix":"10.1097","volume":"48","author":[{"given":"Dirk","family":"M\u00fcller","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, University of Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Herrmann","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University of Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"Schultz","sequence":"additional","affiliation":[{"name":"Radiology-Division of Nuclear Medicine, University of Iowa, Iowa, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Solbach","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University of Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ettrich","sequence":"additional","affiliation":[{"name":"Clinic of Internal Medicine, University of Ulm, Ulm, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Prasad","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University of Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,10,18]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.apradiso.2017.05.006","article-title":"Automated cassette-based production of high specific activity [203\/212Pb]peptide-based theranostic radiopharmaceuticals for image-guided radionuclide therapy for cancer","volume":"127","year":"2017","journal-title":"Appl Radiat Isot"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.2174\/0929867327999200727190423","article-title":"203\/212Pb theranostic radiopharmaceuticals for image-guided radionuclide therapy for cancer","volume":"27","year":"2020","journal-title":"Curr Med Chem"},{"key":"bib3-20250621","article-title":"Mathematical modeling of in vivo alpha particle generators and chelator stability","year":"2021","journal-title":"Cancer Biother Radiopharm"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.3390\/pharmaceutics13122132","article-title":"A physiologically based pharmacokinetic model for in vivo alpha particle generators targeting neuroendocrine tumors in mice","volume":"13","year":"2021","journal-title":"Pharmaceutics"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.3390\/cancers13153676","article-title":"Targeted alpha-particle radiotherapy and immune checkpoint inhibitors induces cooperative inhibition on tumor growth of malignant melanoma","volume":"13","year":"2021","journal-title":"Cancers (Basel)"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00259-018-4220-z","article-title":"Development and dosimetry of 203Pb\/212Pb-labelled PSMA ligands: bringing \u201cthe lead\u201d into PSMA-targeted alpha therapy?","volume":"46","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13550-015-0099-x","article-title":"Twins in spirit\u2014episode I: comparative preclinical evaluation of [(68)Ga]DOTATATE and [(68)Ga]HA-DOTATATE","volume":"5","year":"2015","journal-title":"EJNMMI Res"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1021\/bc0200069","article-title":"Improvement of pharmacokinetics of radioiodinated Tyr(3)-octreotide by conjugation with carbohydrates","volume":"13","year":"2002","journal-title":"Bioconjug Chem"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004464","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:02:39Z","timestamp":1750536159000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,18]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004464","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,18]]}}}